Progenics Pharmaceuticals Inc (PGNX.OQ)
22 Jul 2016
Tue, Jul 19 2016
* Valeant expects to commence sales of relistor tablets in U.S. in Q3 of 2016
* Under agreement, progenics will have use of Selexis CHO-M cell line and sure technology platform
* Progenics pharmaceuticals announces first quarter 2016 financial and business results
* Valeant and Progenics announce pdufa date extension for oral relistor
- Biotech Forum Daily Digest: Progenics Gets Critical FDA Appoval. Spotlight On Alder Biopharmaceuticals
- Progenics: Key FDA Decision Could Power This Under $5 Biopharma Stock
- 2 Must-Have Small Biotechs For July
- Biotech: 2 Attractive Buyout Targets For Under $7 A Share
- Biotech Forum Daily Digest: The Biotech Rally Continues, Relypsa Gets Some Traction, Exelixis Living Up To Its Promise.
- 2 Small Biotech Stocks Poised To Breakout!